This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Enhan Technology Holdings International Co., Ltd., Other. Active years: 2001-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kowloon, KR (2001)
- Hong Kong, CN (2002 - 2008)
Company Filing History:
2 out of 2 
6 out of 834,570 Years Active: 2001-2008
Title: Innovations of Chee-Keung Chung in Neuroprotection and Regeneration
Introduction
Chee-Keung Chung is a notable inventor based in Hong Kong, CN, recognized for his contributions to the fields of neuroprotection and regenerative medicine. With a total of 8 patents to his name, Chung has focused on developing innovative methods to treat neurological disorders and injuries.
Latest Patents
One of Chung's latest patents is titled "Sporoderm-broken germination-activated ganoderma lucidum spores for protection of dopaminergic neurons and treatment of Parkinson's disease." This invention provides a method for treating Parkinson's disease (PD), particularly in its early stages, by orally administering sporoderm-broken germination activated spore powders (GASP) to reduce and/or alleviate symptoms of rotatory behavior in PD. The method aims to reduce the progression of neuron apoptosis and improve the activity of tyrosine hydroxylase (TH), thereby increasing the conversion of hydroxydopamine (DOPA) to dopamine in dopaminergic neurons. Another significant patent addresses the "Effects of sporoderm-broken germination activated ganoderma spores on treatment of spinal cord injury." This invention offers a method for treating patients with spinal cord injuries by administering germination activated spores (GASP), which promote axon regeneration and enhance motor neuron survival in the injured spinal cord.
Career Highlights
Throughout his career, Chee-Keung Chung has worked with various companies, including Enhan Technology Holdings International Co., Ltd. His innovative work has positioned him as a key figure in the development of therapeutic solutions for neurological conditions.
Collaborations
Chung has collaborated with notable individuals in his field, including Siu Kan Tong and Xin Liu, contributing to the advancement of research and development in neuroprotective therapies.
Conclusion
Chee-Keung Chung's innovative patents and research efforts have made significant strides in the treatment of neurological disorders and spinal cord injuries. His work continues to inspire advancements in medical science and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile